ReShape Lifesciences Inc (RSLS)

NASDAQ
Currency in USD
Disclaimer
2.520
+0.090
(+3.70%)
Closed
2.550
+0.030
(+1.19%)
After Hours
Real-time Data
Day's Range
2.430
2.550
52 wk Range
2.210
45.500
Volume
24,943
Prev. Close
2.43
Open
2.43
Day's Range
2.43-2.55
52 wk Range
2.21-45.5
Volume
24,943
Average Volume (3m)
266,355
1-Year Change
-94.26%
Shares Outstanding
2,942,313
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
8.000
Upside +217.460%

People Also Watch

0.2000
INPX
+2.56%
9.980
CXAI
-7.51%
1.390
CFRX
+2.96%

ReShape Lifesciences Inc News

ReShape Lifesciences Inc Analysis

ReShape Lifesciences Inc Company Profile

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation. It also offers ReShapeCare virtual health coaching program, a program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.